mDPR-Val-Cit-PAB-MMAE TFA | MedChemExpress (MCE)
mDPR-Val-Cit-PAB-MMAE TFA is a drug-linker conjugate for ADC (Drug-Linker Conjugates for ADC), consisting of a tubulin polymerization inhibitor MMAE (HY-15162) and an ADC linker (peptide Val-Cit- PAB) composition[1].
Trivial name | mDPR-Val-Cit-PAB-MMAE TFA |
Catalog Number | HY-19813A |
Research Area | Cancer |
CAS# | 2185872-76-6 |
Purity | 99.51% |
SMILES | CC[C@H](C)[C@@H]([C@@H](CC(N1[C@@H](CCC1)[C@@H]([C@@H](C)C(N[C@H](C)[C@@H](O)C2=CC=CC=C2)=O)OC)=O)OC)N(C([C@H](C(C)C)NC([C@H](C(C)C)N(C(OCC3=CC=C(NC([C@H](CCCNC(N)=O)NC([C@H](C(C)C)NC([C@@H](N4C(C=CC4=O)=O)CN)=O)=O)=O)C=C3)=O)C)=O)=O)C.O=C(O)C(F)(F)F |
Size | 1 mg |
Supplier Page | https://www.medchemexpress.com/mdpr-val-cit-pab-mmae-tfa.html |